Daily Caller EXCLUSIVE: Trump’s Broad Ban On Risky Gain-Of-Function Research Nears Completion

From the Daily Caller News Foundation

President Donald Trump could sign a sweeping executive order banning gain-of-function research — research that makes viruses more dangerous in the lab — as soon as May 6, according to a source who has worked with the National Security Council on the issue.

The executive order will take a broad strokes approach, banning research amplifying the infectivity or pathogenicity of any virulent and replicable pathogen, according to the source, who requested anonymity to speak candidly about the anticipated executive action. But significant unresolved issues remain, according to the source, including whether violators will be subject to criminal penalties as bioweaponeers.

The executive order is being steered by Gerald Parker, head of the White House Office of Pandemic Preparedness and Response Policy, which has been incorporated into the NSC. Parker did not respond to requests for comment.

Dear Readers:

As a nonprofit, we are dependent on the generosity of our readers.

Please consider making a small donation of any amount here. Thank you!

In the process of drafting the executive order, Parker has frozen out the federal agencies that have for years championed gain-of-function research and staved off regulation — chiefly Anthony Fauci’s former institute, the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

The latest policy guidance on gain-of-function research, unveiled under the Biden administration in 2024, was previously expected to go into effect May 6. According to a March 25 letter cosigned by the American Society for Microbiology, the Association for Biosafety and Biosecurity International, and Council on Governmental Relations, organizations that conduct pathogen research have not received direction from the NIH on that guidance — suggesting the executive order would supersede the May 6 deadline.

The 2024 guidance altered the scope of experiments subject to more rigorous review, but charged researchers, universities and funding agencies like NIH with its implementation, which critics say disincentivizes reporting. Many scientists say that researchers and NIH should not be the primary entities conducting cost–benefit analyses of pandemic virus studies.

Parker previously served as the head of the National Science Advisory Board for Biosecurity (NSABB), a group of outside experts that advises NIH on biosecurity matters, and in that role recommended that Congress stand up a new government agency to advise on gain-of-function research. Former Centers for Disease Control and Prevention Director Robert Redfield has also endorsed moving gain-of-function research decision making out of the NIH to an independent commission.

“Given the well documented lapses in the NIH review process, policymakers should … remove final approval of any gain-of function research grants from NIH,” Redfield said in a February op-ed.

It remains to be seen whether the executive order will articulate carveouts for gain-of-function research without risks of harm such as research on non-replicative pseudoviruses, which can be used to study viral evolution without generating pandemic viruses.

It also remains to be seen whether the executive order will define “gain-of-function research” tightly enough to stand up to legal scrutiny should a violator be charged with a crime.

Risky research on coronaviruses funded by the NIH at the Wuhan Institute of Virology through the U.S. nonprofit EcoHealth Alliance typifies the loopholes in NIH’s existing regulatory framework, some biosecurity experts say.

Documents obtained through the Freedom of Information Act in 2023 indicated that EcoHealth Alliance President Peter Daszak submitted a proposal to the Pentagon in 2018 called “DEFUSE” describing gain-of-function experiments on viruses similar to SARS-CoV-2 but downplayed to his intended funder the fact that many of the tests would occur in Wuhan, China.

Daszak and EcoHealth were both debarred from federal funding in January 2025 but have faced no criminal charges.

“I don’t know that criminal penalties are necessary. But we do need more sticks in biosafety as well as carrots,” said a biosecurity expert who requested anonymity to avoid retribution from his employer for weighing in on the expected policy. “For instance, biosafety should be a part of tenure review and whether you get funding for future work.”

Some experts say that it is likely that the COVID-19 crisis was a lab-generated pandemic, and that without major policy changes it might not be the last one.

“Gain-of-function research on potential pandemic pathogens caused the COVID-19 pandemic, killing 20 million and costing $25 trillion,” said Richard Ebright, a Rutgers University microbiologist and longtime critic of high-risk virology, to the Daily Caller News Foundation. “If not stopped, gain-of-function research on potential pandemic pathogens likely will cause future lab-generated pandemics.”

Up Next

PRC-Linked Disinformation Claims Conservatives Threaten Chinese Diaspora Interests, Take Aim at PM Carney’s Debate Remark

Don't Miss

DOJ Releases Dossier Of Deported Maryland Man’s Alleged MS-13 Gang Ties

Todayville

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Canada’s Missing Intelligence Command: Convoy Review Takes on New Relevance After FBI Warnings

International / 13 hours ago

Work underway – Trump’s Golden Dome defense shield to be done within four years

Banks / 13 hours ago

Legal group releases report warning Canadians about central bank digital currencies

Daily Caller

Joe Biden Diagnosed With ‘Aggressive’ Prostate Cancer

Published on May 19, 2025

Todayville

From the Daily Caller News Foundation

By Jason Cohen

Former President Joe Biden received a diagnosis of prostate cancer on Friday, according to a Sunday announcement by his personal office.

The statement characterizes the cancer Biden has as “a more aggressive form of the disease” that has metastasized to the bone, but the statement adds that it can be effectively managed. The diagnosis follows renewed scrutiny on Biden’s physical and mental decline, along with its cover-up, ahead of the release of a book on the subject titled “Original Sin” by CNN anchor Jake Tapper and Axios reporter Alex Thompson.

“Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms. On Friday he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone,” the statement reads. “While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians.”

A Gleason score of nine indicates high-grade cancer, meaning that the tumor is more likely to spread aggressively, according to Mount Sinai. A lower Gleason score would indicate that the cancer does not grow as quickly and is less likely to spread elsewhere.

Since leaving office in January, Biden has delivered one major public speech and participated in interviews with “The View” and BBC. In his May 8 appearance on “The View,” he denied reports that he experienced cognitive decline during his presidency.

After Biden’s son Beau passed away from brain cancer in 2015, he decided not to run for president in 2016 before running again and securing the White House in 2020. Excerpts from “Original Sin” and other revelations about the Biden presidency indicate that the former president was in declining physical and mental condition throughout his term, and that the extent of his decline was no longer deniable after his poor performance in the June 2024 debate against President Donald Trump.

Trump issued a statement on Truth Social shortly after news of Biden’s diagnosis broke on Sunday.

“Melania and I are saddened to hear about Joe Biden’s recent medical diagnosis,” Trump wrote. “We extend our warmest and best wishes to Jill and the family, and we wish Joe a fast and successful recovery.”

armed forces

Top Trump Military Official Takes Aim At Absurd Bloat In Navy

Published on May 17, 2025

Todayville

From the Daily Caller News Foundation

By Wallace White

U.S. Navy Secretary John Phelan took aim at the rampant waste in the Navy during a Wednesday posture hearing with the House Appropriations Committee.

Phelan and acting Chief of Naval Operations Adm. James Kilby laid out the Navy’s bloated acquisitions contracting system and inefficient workforce, which employs 56,000 people but only processes two contracts a month per employee on average. Phelan, a former Wall Street executive, stressed his mission is to cut waste and utilize his unorthodox background to promote efficiency in keeping America’s Navy ready to fight and win wars.

Phelan said the Navy processed a total of 217,000 contracts in 2024, with an average employee processing 34 in total.

“I’ll also be honest, when I look at our contracting, it’s poor,” Phelan said during the hearing. “We don’t control our [intellectual property]. We can’t repair stuff. We don’t have very good penalties built in for lack of performance. These are all things we are going to really try to change.”

Phelan already slashed a slew of Navy programs in April in the name of cost savings, worth a grand total of $568 million, according to DefenseScoop. In the hearing, he expressed interest in shrinking the overall workforce while maintaining vital employees.

The secretary also pledged to have the Navy pass a financial audit, even as the Pentagon failed its seventh consecutive audit in 2024. The Defense Department’s budget is set to balloon to over $1 trillion in 2026 as the various branches of the armed forces jockey for funding.

“Accountability is not just a regulatory requirement. It is the bedrock upon which we will build a stronger, more efficient Navy and Marine Corps,” Phelan said in the hearing. “Under my leadership, the Department of the Navy will achieve a clean audit, following the example set by the Marine Corps, which has completed two consecutive unmodified audits.”

While the Navy struggles with overspending and a bloated contract system, it is also struggling to put ships in the water at a time when China is being aggressive in the Pacific Ocean.

The Navy has struggled to maintain its existing ships, while new ships have been plagued by massive delays, with some contractors extending their deadlines for ship delivery by up to three years. China maintains the upper hand in military shipbuilding, surpassing the U.S. Navy’s total ship count in 2020 with 360 ships compared to just 296 in the U.S. fleets, according to a January Congressional Research Service (CRS) report.

Phelan and Kilby aim to shift the Navy’s focus towards shipbuilding to fulfill President Donald Trump’s executive order calling for increased ship production.

“I will lead this department with three focus areas that will guide our Navy and Marine Corps: strengthen shipbuilding and the maritime industrial base, foster an adaptive, accountable, and innovative warfighter culture, improve the health, welfare, and training of our people,” Phelan said during the briefing.